G. Nelkin

发表

Atorvastatin: a potential chemopreventive agent in bladder cancer.

A. Kamat, G. Nelkin, Gina M. Nelkin, 2005, Urology.

Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.

M. Abdelrahim, A. Kamat, W. Kassouf, 2006, Cancer research.

Molecular Mechanism of hTid-1, the Human Homolog of Drosophila Tumor Suppressor l(2)Tid, in the Regulation of NF-κB Activity and Suppression of Tumor Growth

C. Cheng‐Mayer, I. Fidler, D. Fan, 2005, Molecular and Cellular Biology.

Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.

I. Fidler, D. McConkey, D. Davis, 2000, Cancer research.

Advances in Brief Therapy of Human Pancreatic Carcinoma Implants by Irinotecan and the Oral Immunomodulator JBT 3002 Is Associated with Enhanced Expression of Inducible Nitric Oxide Synthase in Tumor-infiltrating Macrophages 1

I. Fidler, D. McConkey, D. Davis, 2000 .

Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.

C. Dinney, A. Kamat, W. Kassouf, 2006, The Journal of urology.

Oxide Synthase in Tumor-infiltrating Macrophages Associated with Enhanced Expression of Inducible Nitric Irinotecan and the Oral Immunomodulator JBT 3002 Is Therapy of Human Pancreatic Carcinoma Implants by Updated

I. Fidler, D. McConkey, D. Davis, 2000 .

Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

A. Sood, C. Landen, Yang Li, 2005, Clinical Cancer Research.